MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

MDT

96.1

-0.44%↓

A

137.81

-0.48%↓

VEEV

224.76

+0.38%↑

HQY

92.67

-0.47%↓

PHR.US

16.99

-0.18%↓

Search

Omnicell Inc

Închisă

SectorSănătate

46.13 -0.58

Rezumat

Modificarea prețului

24h

Curent

Minim

45.27

Maxim

46.4

Indicatori cheie

By Trading Economics

Venit

-177K

5.5M

Vânzări

20M

311M

P/E

Medie Sector

106.279

78.892

EPS

0.51

Marjă de profit

1.758

Angajați

3,600

EBITDA

524K

31M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+8.84% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

696M

2.1B

Deschiderea anterioară

46.71

Închiderea anterioară

46.13

Sentimentul știrilor

By Acuity

50%

50%

149 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

Omnicell Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 dec. 2025, 22:03 UTC

Principalele dinamici ale pieței

Mining Stocks Slip Near the End of Stellar Year

29 dec. 2025, 15:57 UTC

Principalele dinamici ale pieței

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Decline; Yen in Focus -- Market Talk

29 dec. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Manus: Will Continue to Operate From Singapore

29 dec. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dec. 2025, 23:37 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Will Integrate Manus Service Into Products

29 dec. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dec. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dec. 2025, 23:35 UTC

Achiziții, Fuziuni, Preluări

Manus to Join Meta Platforms

29 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Origin: Raise Values Kraken at US$8.65 Billion

29 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dec. 2025, 21:31 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dec. 2025, 21:31 UTC

Achiziții, Fuziuni, Preluări

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin's Kraken Stake to Remain at 22.7%

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin: Additional Interest Offsets Dilution From Raise

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dec. 2025, 21:27 UTC

Achiziții, Fuziuni, Preluări

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dec. 2025, 20:22 UTC

Market Talk

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dec. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dec. 2025, 20:02 UTC

Achiziții, Fuziuni, Preluări

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dec. 2025, 17:36 UTC

Market Talk

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparație

Modificare preț

Omnicell Inc Așteptări

Obiectiv de preț

By TipRanks

8.84% sus

Prognoză pe 12 luni

Medie 50.5 USD  8.84%

Maxim 63 USD

Minim 43 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOmnicell Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

5 ratings

4

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

24.23 / 30.44Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

149 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Omnicell Inc

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
help-icon Live chat